Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
VANCOUVER, BC, Oct. 20, 2021 Finalized study design and protocol mark major milestone to investigate natural Psilocybin VANCOUVER, BC , Oct. 20, 2021 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to have finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived […]
Small Pharma Announces Upgrade to the OTCQB(R) and DTC Eligibility
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce its successful upgrade from the OTC Pink to the OTCQB Venture Market (the “OTCQB”), a United States trading platform that is operated by the OTC Markets Group Inc. in New York. The […]
